Differences in catalytic properties between cerebral cytoplasmic and mitochondrial hexokinases.

Por Thompson, M F, Bachelard, H S
Publicado em 1977

Cerebral-cortex hexokinase. Comparison of properties of solubilized mitochondrial and cytoplasmic activities

Por Thompson, M. F., Bachelard, H. S.
Publicado em 1970

Solubilization of mitochondrial hexokinase from ox cerebral cortex with Triton X-100.

Por Thompson, M F, Bachelard, H S
Publicado em 1969

Cerebral-cortex hexokinases. Elucidation of reaction mechanisms by substrate and dead-end inhibitor kinetic analysis

Por Bachelard, H. S., Clark, A. G., Thompson, M. F.
Publicado em 1971

The kinetic properties and reaction mechanism of histamine methyltransferase from human skin.

Por Francis, D M, Thompson, M F, Greaves, M W
Publicado em 1980

Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis

Por Grima, D. T., Papaioannou, A., Thompson, M. F., Pasquale, M. K., Adachi, J. D.
Publicado no Osteoporos Int (2007)

A Canadian economic analysis of U.S. Oncology Adjuvant Trial 9735

Por Bernard, L.M., Verma, S., Thompson, M.F., Chan, B.C.F., Mittmann, N., Asma, L., Jones, S.E.
Publicado em 2011